Pharma Deutschland e.V
Budget
€300 — €0
EP Access
1
accredited persons
Staff
8
2.75 FTE
EU Grants
None
Mission & Goals
Pharma Deutschland e.V. represents the entire spectrum of the Pharmaceutical Industry, in particular prescription and over-the-counter medicines, material and dental medical devices as well as digital health and care applications. Pharma Deutschland is the pharmaceutical industry association with the largest number of members in Germany. It represents the interests of around 400 member companies that employ approximately 80,000 people in Germany. Globally active pharmaceutical manufacturers are just as actively involved in the diverse work of the association as the broadly represented medium-sized companies.
EU Legislative Interests
- EU Pharmaceutical Strategy - Revision of the general pharmaceutical legislation - Revision on EU legislation on medicines for children and for rare diseases - Health Technology Assessment - Falsified Medicines Directive - Pharmacovigilance framework - Clinical Trials Regulation - Sustainability & Pharmaceuticals in the environment (e.g. - Urban Waste Water treatment directive and Water Quality) - Health Claims Regulation - Intellectual Property / Revision of the legislation on supplementary protection certificates (SPCs) - European Health Data Space - EMA Mandate - European Health Emergency Preparedness and Response Authority (HERA) - Artificial Intelligence / AI Act - Revision of Medical Device Regulation - Security of supply / Critical Medicines Act - Biotech Act - Competitiveness / Industrial Strategy - Life Science Strategy - Medical Countermeasures Strategy - EU public procurement reform
Communication Activities
Publications(exerpt): - Opinion on European Health Data Space (EHDS) - Stellungnahme zum Trilog für eine Verordnung des Europäischen Parlaments und des Rates zu einer verstärkten Rolle der Europäischen Arzneimittel-Agentur bei der Krisenvorsorge und dem Krisenmanagement in Bezug auf Arzneimittel und Medizinprodukte - Stellungnahme zur "Evaluation and Revision of the General Pharmaceutical Legislation" - Position Paper on the Inception Impact Assessment of the European Commission on building a European Health Emergency Preparedness and Response Authority (HERA) - Positionspapier: Herausforderungen bei der Implementierung der MDR - Positionspapier zum EU-Regulierungsrahmen für Künstliche Intelligenz - Stellungnahme zur Revision der EU-Arzneimittel-Gesetzgebung - Positionspapier zur Überarbeitung der kommunalen Abwasserrichtlinie - Positionspapier zur Europawahl - Stellungnahmen zu den Implementierungsrechtsakten im Zusammenhang mit EU-HTA - Stellungnahme zum Critical Medicines Act - Positionen zum Biotech Act
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
German Chemical Industry Association (VCI) https://www.vci.de/startseite.jsp Critical Medicines Alliance (CMA)https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en AESGP (Association Européenne des Spécialités Pharmaceutiques Grand Public) https://aesgp.eu/ Deutsche Akademie für Integrative Medizin (DAfIM) https://dafim.info/ action medeor https://medeor.de/de/ Initiative medicines for children“ (“Initiative Arzneimittel für Kinder”, IKAM) http://www.arzneimittel4kids.de/ Cooperation Phytopharmaceuticals https://www.koop-phyto.org/ Research Association of Drug Manufacturers (FAH) https://fah-bonn.de/ INTEGRITAS, the “Association for fair advertising of remedies" https://www.integritas-hwg.de/
Organisation Members
https://www.pharmadeutschland.de/der-verband/unsere-mitglieder/
Commissioner Meetings
No recorded meetings with EU commissioners.